INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
TN

Thornberry Nancy

DirectorCIK 0001797826

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 2
Max Insider Score21
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
21
TN
Thornberry NancyDirector
DNLIDenali Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$247K
10.8K sh
Sep 2, 2026Sep 4, 2026
traded Sep 2, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Denali Therapeutics Inc.Director · Sep 4, 2026
  • Insider ofevidence
    Schrodinger, Inc.Director · Jun 23, 2026
10
TN
Thornberry NancyDirector
DNLIDenali Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL
$15K
615 sh
Sep 2, 2026
Sep 4, 2026
traded Sep 2, 2026
+2d
SEC FORM 4

Evidence

17
TN
Thornberry NancyDirector
SDGRSchrodinger, Inc.
Grant or award
A—
8,141 sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC FORM 4

Evidence

9
TN
Thornberry NancyDirector
SDGRSchrodinger, Inc.
Grant or award
A—
13.3K sh
Jun 22, 2026Jun 23, 2026
traded Jun 22, 2026
+1dSEC FORM 4

Evidence